UK parses merits of value-based drug pricing

被引:0
|
作者
Moran, Nuala
机构
关键词
D O I
10.1038/nbt0407-369
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
No abstract available
引用
收藏
页码:369 / 370
页数:2
相关论文
共 50 条
  • [1] UK parses merits of value-based drug pricing
    Nuala Moran
    Nature Biotechnology, 2007, 25 : 369 - 370
  • [2] Value-based pricing of drugs in the UK
    Webb, David J.
    Walker, Andrew
    LANCET, 2007, 369 (9571): : 1415 - 1416
  • [3] Value-based drug system proposed in UK
    Collier, Roger
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (17) : E773 - E774
  • [4] Grounding Value-Based Drug Pricing in Population Health
    Kaltenboeck, Anna
    Calsyn, Maura
    Frederix, Geert W. J.
    Lowenthal, Justin
    Mitchell, David
    Rector, Bruce
    Sarpatwari, Ameet
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1290 - 1292
  • [5] VALUE-BASED PRICING IN THE UK: DEVELOPING AN EVALUATION FRAMEWORK FOR BURDEN OF ILLNESS
    Easley, C.
    Tang, J.
    VALUE IN HEALTH, 2011, 14 (07) : A236 - A236
  • [6] Value-based drug pricing in the Biden era: Opportunities and prospects
    Neumann, Peter J.
    Ollendorf, Daniel A.
    Cohen, Joshua T.
    HEALTH SERVICES RESEARCH, 2021, 56 (06) : 1093 - 1099
  • [7] Value-Based Pricing and State Reform of Prescription Drug Costs
    Hwang, Thomas J.
    Kesselheim, Aaron S.
    Sarpatwari, Ameet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07): : 609 - 610
  • [8] VALUE-BASED PRICING IN THE UK AND POTENTIAL PATIENT ACCESS HURDLES TO INNOVATIVE DRUGS
    Papadopoulou, K.
    Grosvenor, A.
    VALUE IN HEALTH, 2013, 16 (07) : A492 - A492
  • [9] The Office of Fair Trading report: a prescription for value-based drug pricing
    Minhas, Rubin
    Moon, James C.
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2007, 100 (05) : 216 - 218
  • [10] THE VALUE OF INNOVATION UNDER VALUE-BASED PRICING
    Moreno, S. G.
    VALUE IN HEALTH, 2016, 19 (03) : A296 - A296